生命科学资讯

Novartis shakes up early pipeline with 6 culls and 2 new cancer candidates

Lilly drops 3 pipeline drugs, including gene therapy, from $1B Prevail buyout

Rare pediatric PRV program reauthorized until 2029 via government funding law

Trump signs funding bill with PBM reforms, hospital-at-home and telehealth extensions

Financings for Feb. 4, 2026

In the clinic for Feb. 4, 2026

Other news to note for Feb. 4, 2026

Regulatory actions for Feb. 4, 2026

BARDA offers $100M in prize money for antiviral development

PharosAI and 10x Genomics partner to transform cancer research with AI and spatial biology - marketscreener.com

Novo shares tumble by double digits on grim sales outlook

Lilly soars again as fast-selling weight loss drugs top Wall Street projections

GSK's new CEO looking for $2B to $4B deals 'hiding in plain sight'

Medtronic steps up with up to $585M deal for Israeli devicemaker CathWorks

FDA demands better response from Abbott over Libre inspection violations

Preclinical stem cell biotech PrimeGen takes SPAC route to Nasdaq

Hims & Hers to sell Grail’s Galleri multi-cancer blood test via its digital health platform

The Zacks Analyst Blog Highlights Alphabet, Apple, Thermo Fisher Scientific and New England Realty Associates - Nasdaq

Pharosai and 10X Genomics Partner to Transform Cancer Research with Ai and Spatial Biology - marketscreener.com

Illumina Wildlife Genomics Deal Highlights New Conservation And Valuation Story - simplywall.st